Are you Dr. Shapira?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 28 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4015 S Cobb Dr Se
Suite 245
Smyrna, GA 30080Phone+1 770-333-0093Fax+1 770-432-2643
Summary
- Dr. Nathan Shapira, MD is a board certified psychiatrist in Smyrna, Georgia. He is currently licensed to practice medicine in Georgia, Florida, and Ohio.
Education & Training
- University of Cincinnati Medical Center/College of MedicineResidency, Psychiatry, 1995 - 1999
- Vanderbilt University School of MedicineClass of 1995
Certifications & Licensure
- GA State Medical License 2006 - 2026
- OH State Medical License 1996 - 2014
- FL State Medical License 1999 - 2013
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Treatment of Self-Injurious Behavior in Individuals With Prader-Willi Syndrome Start of enrollment: 2002 Jul 01
- Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression Start of enrollment: 2010 Nov 01
- Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder Start of enrollment: 2011 Jan 01
Publications & Presentations
PubMed
- 74 citationsDouble-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder.Heather A. Berlin, Lorrin M. Koran, Michael A. Jenike, Nathan A. Shapira, William F. Chaplin
The Journal of Clinical Psychiatry. 2011-05-01 - 222 citationsDeep Brain Stimulation for Intractable Obsessive Compulsive Disorder: Pilot Study Using a Blinded, Staggered-Onset DesignWayne K. Goodman, Kelly D. Foote, Benjamin D. Greenberg, Nikki Ricciuti, Russell M. Bauer
Biological Psychiatry. 2010-03-15 - 505 citationsDeep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience.Benjamin D. Greenberg, Lutgardis Gabriëls, Donald A. Malone, Ali R. Rezai, G M Friehs
Molecular Psychiatry. 2010-01-01